Important Notice:
- The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws. On November 29, 2019, the company received the CSRC's Administrative Penalty and Market Ban Advance Notice (Document No. [2019]149). According to the findings in the notice, the company's net profits were negative for four consecutive years from 2015 to 2018.
- The company and some involved parties have made statements, defenses, and requested hearings regarding the administrative penalties proposed by the CSRC. Hunan Qianshan Pharmaceutical Machinery Co., Ltd. received the Investigation Notic